Moscow -A separate clinical study would be needed to include pregnant women in the COVID-19 vaccination campaign, Alexander Gintsburg, the Head of the Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology, said on Tuesday.
“Certainly, it is necessary to conduct a separate clinical study, which has not been carried out yet,” Gintsburg said at a roundtable on COVID-19, hosted by the Rossiya Segodnya International Information Agency.
On Aug. 11, Russia became the first country in the world to register a coronavirus vaccine, named Sputnik V and developed by the Gamaleya Institute.
However, the number of coronavirus cases worldwide passed 30 million on Friday, according to the Johns Hopkins University tracker, as the World Health Organisation ( WHO) said daily case numbers were growing at an “alarming rate” in Europe.
The global death toll stands at 943,203 people and is expected to pass 1 million by Oct.1.
The U.S. accounts for than 22 per cent of global cases, at 6.67m, and nearly 200,000 fatalities.